Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma: A broad survey using high-throughput tissue microarray

Cancer

Volumn 95, Issue 11, 2002, Pages 2346-2352

  Wang, Yi ^a,b   Wu, Meng Chao ^b   Sham, Jonathan S T ^a   Zhang, Weigou ^b   Wu, Wei Qing ^b   Guan, Xin Yuan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER INJURY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MUTATION; ONCOGENE; ONCOGENE AIB1; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS;

CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 1; DISEASE PROGRESSION; DNA, NEOPLASM; GENE AMPLIFICATION; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; TRANSCRIPTION FACTORS;

EID: 0036890030     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10963     Document Type: Article

References (33)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-750.
2. Feitelson MA. Hepatitis B virus in hepatocarcinogenesis. J Cell Physiol. 1999;181:188-202.
3. Aguayo A, Patt YZ. Liver cancer. Clin Liver Dis. 2001;5:479-507.
4. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Yu L, Nagasue N. Proposal of invasiveness score to predict recurrence and survival after curative resection for hepatocellular carcinoma. Surgery. 1997;122:571-577.
5. Rashidi B, An Z, Sun FX, et al. Efficacy of intra-hepatectomy 5-FU on recurrence and metastasis of human hepatocellular carcinoma in nude mice. Int J Cancer. 2001;91:231-235.
6. Okusaka T, Okada S, Nose H, et al. The prognosis of patients with hepatocellular carcinoma of multicentric origin. Hepatogastroenterology. 1996;43:919-925.
7. McPeake JR, O'Grady JG, Zaman S, et al. Liver transplantation for primary hepatocellular carcinoma: Tumor size and number determine outcome. J Hepatol. 1993;18:226-234.
8. Marchio A, Meddeb M, Pineau P, et al. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer. 1997;18:59-65.
9. Guan X-Y, Fang Y, Sham JST, et al. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer. 2000;29:110-116.
10. Wong N, Lai P, Lee SW, et al. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: Relationship to disease stage, tumor size, and cirrhosis. Am J Pathol. 1999;154:37-43.
11. Lin YW, Sheu JC, Huang GT, et al. Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridization in Taiwan, Eur J Cancer. 1999;35:652-658.
12. Obaya AJ, Mateyak MK, Sedivy JM. Mysterious liaisons: The relationship between c-myc and the cell cycle. Oncogene. 1999;18:2934-2941.
13. Ghadimi BM, Schrock E, Walker RL, et al. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinoma. Am J Pathol. 1999;154:525-536.
14. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarray for high-throughput molecular profiling of tumor specimens. Nature Med. 1998;4:844-847.
15. Bubendorf L, Kononen J, Koivisto P, et al. Survey of gene amplification during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarray. Cancer Res. 1999;59:803-806.
16. Bubendorf L, Kolmer M, Kononen J, et al. Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst. 1999; 91:1758-1764.
17. Richter J, Wagner U, Kononen J, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol. 2000; 157:787-794.
18. Simon R, Burger H, Brinkschmidt C, et al. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol. 1998;185:345-351.
19. Tirkkonen M, Tanner M, Karhu R, et al. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer. 1998;21:177-184.
20. Qin L-X, Tang Z-Y, Sham JST, et al. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res. 1999;59:5662-5665.
21. Jenkins RB, Qian J, Lieber MM, Bostwick DG. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res. 1997;57:524-531.
22. Weber RG, Pietsch T, Schweinitz DV, Lichter P. Characterization of genomic alterations in hepatoblastoma: A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol. 2000;157:571-578.
23. Anzick SL, Kononen J, Walker RL, et al. AIB1, a novel estrogen receptor co-activator amplified in breast and ovarian cancer. Science. 1997;277:965-968.
24. Zhou XD, Tang ZY, Yang BH, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer. 2001;91:1479-1486.
25. Suehiro T, Matsumata T, Itasaka H, Yamamoto K, Kawahara N, Sugimachi K. Clinicopathologic features and prognosis of resected hepatocellular carcinoma of varied size with special reference to proliferating cell nuclear antigen. Cancer. 1995;76:399-405.
26. Sakakura C, Hagiwara A, Yasuoka R, et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer. 2000;89:217-223.
27. Shuto T, Hirohashi K, Ikebe T, et al. Additional hepatocellular carcinomas undetectable before surgery. World J Surg. 2000;24:1566-1569.
28. Yasui M, Harada A, Nonami T, et al. Potentially multicentric hepatocellular carcinoma: Clinicopathologic characteristics and postoperative prognosis. World J Surg. 1997;21:860-864.
29. Sakamoto M, Hirohashi S, Tsuda H, Shimosato Y, Makuuchi M, Hosoda Y. Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. Am J Surg Pathol. 1989;13:1064-1067.
30. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. Mutation pattern of the p53 gene as a diagnosis marker for multiple hepatocellular carcinoma. Cancer Res. 1992;52:3674-3678.
31. Wilkens L, Martin B, Flemming P, Klempnauer J, Kreipe HH. Differentiation of multicentric origin from intra-organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization. J Pathol. 2000;192:43-51.
32. Ouchi K, Sugawara T, Fujiya T, et al. Prediction of recurrence and extratumor spread of hepatocellular carcinoma following resection. J Surg Oncol. 2000;75:241-245.
33. Koike Y, Shiratori Y, Sato S, et al. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus - An analysis of 236 consecutive patients with a single lesion. Hepatology. 2000;32:1216-1223.